Drug intelligence / Profile preview

ModCAR-GRP78

Development stage
Preclinical
Lead developer
Hauul Bio
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

ModCAR-GRP78 is a modular chimeric antigen receptor (CAR) cell therapy being developed by Hauul Bio for the treatment of solid tumors, including triple-negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and colorectal cancer (CRC). The therapy utilizes a modular CAR platform designed to target GRP78 (Glucose-Regulated Protein 78), a chaperone protein that is typically located in the endoplasmic reticulum but becomes overexpressed on the surface of various cancer cells. By targeting surface-expressed GRP78, ModCAR-GRP78 aims to selectively eliminate tumor cells while minimizing off-target effects. The program is currently in the preclinical stage of development.

Other names
ModCAR-GRP78ModCAR-GRP-78ModCAR-GRP 78
02

Targets

HSPA5 (Heat shock protein family A member 5)

Beyond the preview

Go deeper on ModCAR-GRP78.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ModCAR-GRP78.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call